Literature DB >> 17669633

DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injury.

A Milman1, O Zohar, R Maayan, R Weizman, C G Pick.   

Abstract

Mild traumatic brain injury (mTBI) is characterized by diffused symptoms, which when combined are called "post-concussion syndrome". Dehydroepiandrosterone sulfate (DHEAS) is a neuroactive neurosteroid. Previously, we have reported that closed head mTBI causes long lasting cognitive deficits and depressive-like behavior. In the present study we describe the effects of DHEAS on the behavior of mice that suffered closed head mTBI. Following the induction of mTBI, mice were treated once a week with DHEAS (s.c. 20 mg/kg) and their performance in the passive avoidance test and the forced swimming test (FST) were evaluated 7, 30, 60 and 90 days post-injury. The most important interactions were between injury and injection (passive avoidance; p<0.001 and FST; p=0.001), meaning that DHEAS has beneficial effects only when given to injured animals. Our results demonstrate that the long-term cognitive and behavioral effects induced by mTBI may be improved by a repeated weekly treatment with DHEAS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669633     DOI: 10.1016/j.euroneuro.2007.05.007

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  15 in total

1.  The effect of injury severity on behavior: a phenotypic study of cognitive and emotional deficits after mild, moderate, and severe controlled cortical impact injury in mice.

Authors:  Patricia M Washington; Patrick A Forcelli; Tiffany Wilkins; David N Zapple; Maia Parsadanian; Mark P Burns
Journal:  J Neurotrauma       Date:  2012-08-03       Impact factor: 5.269

2.  Minimal traumatic brain injury induce apoptotic cell death in mice.

Authors:  V Tashlykov; Y Katz; A Volkov; V Gazit; S Schreiber; O Zohar; C G Pick
Journal:  J Mol Neurosci       Date:  2008-07-24       Impact factor: 3.444

Review 3.  Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation.

Authors:  Patricia B de la Tremblaye; Darik A O'Neil; Megan J LaPorte; Jeffrey P Cheng; Joshua A Beitchman; Theresa Currier Thomas; Corina O Bondi; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2017-05-30       Impact factor: 8.989

4.  Elucidating the severity of preclinical traumatic brain injury models: a role for functional assessment?

Authors:  Ryan C Turner; Reyna L VanGilder; Zachary J Naser; Brandon P Lucke-Wold; Julian E Bailes; Rae R Matsumoto; Jason D Huber; Charles L Rosen
Journal:  Neurosurgery       Date:  2014-04       Impact factor: 4.654

5.  The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI).

Authors:  Shahaf Edut; Vardit Rubovitch; Shaul Schreiber; Chaim G Pick
Journal:  Psychopharmacology (Berl)       Date:  2010-12-01       Impact factor: 4.530

6.  Treatment of mild traumatic brain injury with an erythropoietin-mimetic peptide.

Authors:  Claudia S Robertson; Robert Garcia; Samson Sujit Kumar Gaddam; Raymond J Grill; Carla Cerami Hand; Tian Siva Tian; H Julia Hannay
Journal:  J Neurotrauma       Date:  2012-09-20       Impact factor: 5.269

7.  DHEA and cognition in HIV-positive patients with non-major depression.

Authors:  Mark Bradley; Martin McElhiney; Judith Rabkin
Journal:  Psychosomatics       Date:  2012-01-31       Impact factor: 2.386

Review 8.  Traumatic brain injury using mouse models.

Authors:  Yi Ping Zhang; Jun Cai; Lisa B E Shields; Naikui Liu; Xiao-Ming Xu; Christopher B Shields
Journal:  Transl Stroke Res       Date:  2014-02-05       Impact factor: 6.829

Review 9.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

10.  Current treatment options for depression after mild traumatic brain injury.

Authors:  Esther Bay
Journal:  Curr Treat Options Neurol       Date:  2009-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.